Medical News

RSS

Medizone International announces new results on Asepticsure sterilization system

Medizone International, Inc. (OTC Bulletin Board: MZEI) announces that following several months of research, AsepticSure(TM) can now achieve a level of bacterial decontamination heretofore unseen in open space settings using conventional means.

11 Nov 2009

Poniard Pharmaceuticals to present picoplatin Phase 2 trial data at the AACR-NCI -EORTC conference

Poniard Pharmaceuticals, Inc. today announced that the Company will present updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC) and final results from its Phase 1 cardiac safety trial.

11 Nov 2009

New insight into how brain responds when people experience an unexpected or traumatic event

In a new study, psychologists at the University of Alabama at Birmingham (UAB) are able to see in detail for the first time how various regions of the human brain respond when people experience an unexpected or traumatic event. The study could lead to the creation of biological measures that could identify people with post-traumatic stress disorder (PTSD) or identify PTSD sufferers who would benefit from specific treatments.

11 Nov 2009

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

11 Nov 2009

Particle Sciences expands operations by acquiring new additional space

Particle Sciences Inc., a leading pharmaceutical CRO, has further expanded their capabilities by the acquisition of additional space bringing their total to approximately 21,000 sq ft.

11 Nov 2009

Allos Therapeutics awards NCCN a grant to evaluate pralatrexate

NCCN recently received a research grant from Allos Therapeutics, Inc. to evaluate the role of pralatrexate in the treatment of select hematologic malignancies and solid tumors. Pralatrexate is the only agent currently approved by the FDA to treat patients with relapsed or refractory peripheral T-cell lymphoma. Investigators from NCCN Member Institutions are eligible to apply for the research funding.

11 Nov 2009

Online community launched to help families affected by PTSD

Since the Vietnam Era, the American psychiatric community has recognized the returning war veterans’ affliction of what is now commonly known as Post Traumatic Stress Disorder (PTSD).

11 Nov 2009

Money-saving tips for healthy, beautiful hair

These days, saving a little money here and there is all the rage. Even small changes - carpooling to work or making coffee at home - can really add up. But when it comes to cutting back on hair care, many people might be hesitant to make significant changes for fear that it could impact their looks and the health of their hair. That's where a dermatologist can help.

11 Nov 2009

"Microsoft Health Tech Today" showcases how software innovation is improving global health

Microsoft Corp. today announced "Microsoft Health Tech Today," a fast-paced online video series designed to showcase how software innovation is improving health around the world. The show, at the intersection of health and information technology, highlights the latest industry trends and features examples of proven solutions that are improving health and changing lives for clinicians, patients and consumers worldwide.

11 Nov 2009

Women face higher risk of post-stroke depression

Depression occurs in as many as one-third of patients after a stroke, and women are at somewhat higher risk, according to a large new review of studies. Post-stroke depression is associated with greater disability, reduced quality of life and an increased risk of death.

11 Nov 2009

New mapping technology to treat patients with heart rhythm disorders

Physicians with California Pacific Medical Center are among the first in the nation to use a new advanced mapping technology to help treat patients suffering from debilitating and potentially dangerous heart rhythm disorders.

11 Nov 2009

Avanir Pharmaceuticals unveils Star trial results for Zenvia in the treatment of PBA

AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA).

11 Nov 2009

Tel Aviv University develops innovative algorithms to combat Intra-uterine growth restrictions for healthy babies

When a fetus is smaller than expected for the number of weeks of pregnancy, due to associated problems like a poorly developed heart, health concerns as severe as brain damage can result.

11 Nov 2009

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine.

11 Nov 2009

GeckoSystems' securities available for trading on the OTC market

GeckoSystems Intl. Corp. announced today that its Common Stock is now quoted in the U.S. over-the-counter markets, on the Pink Sheets Current Information tier, under the ticker symbol GCKO. GeckoSystems is a dynamic leader in the emerging mobile robotics industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™."

11 Nov 2009

Pfizer and BMP Sunstone team up to promote Depo-Provera, a product for treating endometriosis

Pfizer China and BMP Sunstone Corporation today announced a strategic partnership to exclusively import, distribute and promote Depo-Provera (Medroxy-progesterone Acetate), a Pfizer product used to treat endometriosis, in China. Endometriosis is a medical condition in women of childbearing age that can cause significant pain.

11 Nov 2009

Academic Health Center receives 128 grants totaling nearly $35 million in federal stimulus money

Academic Health Center scientists, physicians, and research centers have attracted 128 grants totaling nearly $35 million in federal stimulus money (as of Nov. 10) since the American Recovery and Reinvestment Act was approved in February 2009. This will result in a total economic impact of more than $105 million; according to the National Institutes of Health, $1 of research funding multiplies to more than $2 of goods and services in the economy.

11 Nov 2009

NIDA supports new drug detection research

Every time a person snorts cocaine, it doesn't just go to his or her head: It also provokes a response in the immune system, creating special biomolecules that may serve as a permanent record of each exposure.

11 Nov 2009

Mylan subsidiary receives FDA approval for its Lansoprazole DR Capsules ANDA

Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Lansoprazole Delayed-release (DR) Capsules, 15 mg and 30 mg. This product is shipping immediately and will be sold under the Mylan Pharmaceuticals brand.

11 Nov 2009

Hoag Memorial Hospital Presbyterian to implement complete SIS Solution at Hoag Hospital Irvine

Hoag Memorial Hospital Presbyterian in Newport Beach, CA has expanded its partnership with Surgical Information Systems (SIS) by adding anesthesia, business intelligence and tissue management capabilities to its existing system, and by extending the SIS Solution to Hoag Hospital Irvine, which is scheduled to open in 2010.

11 Nov 2009

Medical News

Medizone International announces new results on Asepticsure sterilization system

Poniard Pharmaceuticals to present picoplatin Phase 2 trial data at the AACR-NCI -EORTC conference

New insight into how brain responds when people experience an unexpected or traumatic event

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Particle Sciences expands operations by acquiring new additional space

Allos Therapeutics awards NCCN a grant to evaluate pralatrexate

Online community launched to help families affected by PTSD

Money-saving tips for healthy, beautiful hair

"Microsoft Health Tech Today" showcases how software innovation is improving global health

Women face higher risk of post-stroke depression

New mapping technology to treat patients with heart rhythm disorders

Avanir Pharmaceuticals unveils Star trial results for Zenvia in the treatment of PBA

Tel Aviv University develops innovative algorithms to combat Intra-uterine growth restrictions for healthy babies

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

GeckoSystems' securities available for trading on the OTC market

Pfizer and BMP Sunstone team up to promote Depo-Provera, a product for treating endometriosis

Academic Health Center receives 128 grants totaling nearly $35 million in federal stimulus money

NIDA supports new drug detection research

Mylan subsidiary receives FDA approval for its Lansoprazole DR Capsules ANDA

Hoag Memorial Hospital Presbyterian to implement complete SIS Solution at Hoag Hospital Irvine

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News